Drug · DIN 02359545
JAMP-RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 23, 2010; first marketed December 23, 2010.
- Drug Identification Number (DIN)
- 02359545
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 1.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 10, 2010: NOC 11924Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “jamp-risperidone”. A notice may cover another product or only some lots: read it to see what it covers.
- JAMP-Risperidone 0.25mg: Out of specification (Stability)November 19, 2025 · Drugs · Product quality · Type III
- JAMP-RISPERIDONE: may contain foreign matter particlesMay 30, 2025 · Drugs · Product safety · Type III
Other DINs named JAMP-RISPERIDONE
- DIN 02359529 · Marketed
- DIN 02359537 · Marketed
- DIN 02359553 · Marketed
- DIN 02359561 · Marketed
- DIN 02359588 · Marketed